MAYFAIR LABORATORIES LIMITED

What MAYFAIR LABORATORIES LIMITED does

Mayfair Laboratories Limited is a UK-based diagnostic laboratory incorporated in 2020 and headquartered in Manchester, operating as a private limited company. It offers a broad menu of clinical diagnostic services spanning haematology, biochemistry, microbiology, immunology, histopathology, and molecular diagnostics, alongside preventive health check packages priced from £59. Its stated customer base spans walk-in patients, NHS-affiliated healthcare providers, and employer or health-plan clients, and the company claims a footprint of ten or more specialized diagnostic centers across three countries.

The company's product stack combines traditional laboratory services with two distinct newer offerings. The first is WACure, a digital healthcare platform that integrates with EMIS and NHS systems and supports SMS, WhatsApp, and video consultations, prescription routing, and clinician referrals — positioning Mayfair as both a lab operator and an emerging integrated-care software vendor. The second is COLOTECT, a non-invasive colorectal cancer screening assay distributed through a partnership with BGI Genomics, which extends Mayfair into molecular oncology screening without internal assay development.

The business model rests on fee-for-service diagnostic testing, B2B contracts with healthcare providers and employer-sponsored plans, and a high-volume free walk-in patient program reportedly handling 1,381 visits per month that functions as a patient-acquisition funnel. The company reports 7,154 tests and patients served cumulatively since 2022 and a 98% client satisfaction rate, with GDPR compliance cited. The publicly disclosed management team is small (a Director, an IT Manager, a Diagnostic Systems Department Manager, and a Graphic Designer), no external funding has been disclosed, and there is a notable discrepancy between the 2020 incorporation date and the company's marketing claim of '25+ years of experience'.

Name

MAYFAIR LABORATORIES LIMITED

Legal name

Mayfair Laboratories Limited

Website

https://mayfairlabs.co.uk

Company type

Private

Founded year

2020

Operating status

Operating

Short description

Mayfair Laboratories is a UK-based Manchester diagnostic laboratory offering routine and specialized testing, the COLOTECT colorectal screening product via its BGI Genomics partnership, and the WACure digital platform with NHS/EMIS integration, serving patients, providers, and employers.

Ownership category

akta.pro rank

Product category

Diagnostic Laboratory Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Reference & Esoteric Testing Laboratories (HLAFAMAJ)

akta.pro secondary industries

Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB), Clinical Chemistry & Immunoassay Laboratories (HLAFAMAB), Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays) (HLAAAMAC), Clinical Chemistry, Hematology & Coagulation Testing (Trial Support) (HLAGAEAE)

Keywords

• Diagnostic laboratory testing
• Medical laboratory services
• Clinical pathology testing
• Digital healthcare platform
• Healthcare consultancy services

Headquarters

HQ city

Manchester

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Laboratory Diagnostic Testing Services: Comprehensive diagnostic testing including hematology (Complete Blood Count, Blood Group, ESR), biochemistry (Liver/Kidney Function, Glucose/Lipid Profile, HbA1c, CRP), coagulation (PT/INR, APTT, D-Dimer), trace elements (Iron, Calcium, Magnesium), urinalysis, hormone analysis (Thyroid, Reproductive, Cortisol), and oncology markers. Revenue generated through test fees paid by patients, healthcare providers, employers, and health plans.
2. Genetic/Specialized Testing: Specialized genetic testing services including COLOTECT colorectal cancer screening, with sample collection kits sent to customers and processing at the laboratory. Higher-value specialized testing with longer turnaround times (1-2 business days vs 2-4 hours for routine tests).
3. Professional Consultancy Services: Healthcare consultancy services for healthcare providers and organizations seeking expert guidance on laboratory medicine and diagnostic solutions.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

Mayfair Laboratories Limited operates a UK-based clinical laboratory providing comprehensive diagnostic testing services across hematology, biochemistry, coagulation, trace elements, urinalysis, hormone analysis, and oncology markers. The company also offers the COLOTECT non-invasive colorectal cancer screening test in partnership with BGI Genomics, the WACure digital healthcare platform for patient-provider connectivity with NHS and EMIS integration, and professional consultancy services for healthcare providers and organizations.

Product overview

Mayfair Laboratories operates as a UK-based healthcare laboratory offering a dual-portfolio approach: (1) physical laboratory diagnostic services under the General Diagnostic Tests umbrella, covering hematology, biochemistry, coagulation, trace elements, urinalysis, and hormone analysis categories, and (2) a digital healthcare platform called WACure that provides on-demand health support with multi-channel communication and integration with NHS and EMIS health systems. Additionally, the company offers specialized diagnostic products including COLOTECT, a non-invasive colorectal cancer screening test developed in partnership with BGI Genomics with 96.08% sensitivity.

Differentiator

Problem solved

Functional benefit

Brands

• WACure: A groundbreaking digital healthcare platform designed to simplify and enhance access to medical support and guidance. Connects patients, caregivers, and healthcare providers through secure multi-channel communication including SMS, WhatsApp, and video.
• COLOTECT

Products and services

• General Diagnostic Tests

Quantifiable outcome

• 7.154 tests and patients served since 2022
• +4 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

Feature2 records

Partnerships

Two partnerships are on record, tiered core.

• BGI GenomicscoreTechnology or IntegrationStrategic partnership with BGI Genomics, the world's largest genetics company, for the COLOTECT colorectal cancer screening test. This partnership provides access to advanced DNA marker technology and BGI's expertise in genetic testing innovation. COLOTECT achieves 96.08% sensitivity for colorectal cancer detection using non-invasive stool sample analysis. The partnership enables Mayfair Laboratories to offer cutting-edge genetic testing services in the UK market.
• WACurecoreTechnology or IntegrationWACure is Mayfair Laboratories' proprietary digital healthcare platform that transforms access to personalized healthcare solutions. The platform enables on-demand health support, secure multi-channel communication (SMS, WhatsApp, video), and smart integration with major health systems including NHS and EMIS. WACure connects patients, caregivers, and healthcare providers for seamless healthcare coordination, bringing care closer to users wherever they are.

Scale indicators6 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• CityDoc: UK private health clinic offering blood testing, sexual health screening, and travel vaccines with walk-in services. Comparable to Mayfair in walk-in model, individual patient focus, and quick turnaround on routine diagnostic panels.
• Randox Health: UK-based private diagnostics company offering comprehensive blood testing, health checks, and direct-to-consumer testing services. Closely comparable to Mayfair in walk-in testing model, focus on routine and specialized panels, and consumer-facing health screening positioning.
• London Medical Laboratory: UK private diagnostic laboratory offering walk-in blood testing with same-day results across a similar range of hematology, biochemistry, and hormone panels. Closely matches Mayfair's walk-in, no-appointment-required GTM and rapid turnaround positioning.
• Bluecrest Health Screening: UK-based direct-to-consumer health screening provider offering comprehensive blood tests and health assessments with home self-collection kits. Comparable to Mayfair in serving individual consumers seeking preventive diagnostics outside NHS pathways.

Others

• BGI Genomics: World's largest genetics company providing the COLOTECT technology that Mayfair distributes in the UK. Not a direct competitor but a critical partner whose technology underpins Mayfair's flagship product offering.

Broad incumbents

• The Doctors Laboratory (TDL): One of the UK's largest private medical laboratories offering comprehensive pathology and diagnostic testing services to clinicians, hospitals, and patients. Directly comparable to Mayfair's core general diagnostic testing offering, but with significantly larger scale and established NHS/private hospital contracts.
• Nuffield Health: UK-wide private hospital and diagnostics operator offering blood testing and health assessments as part of broader health services. Comparable on diagnostic testing capabilities and corporate/employer health program offerings, but operates at much larger scale.
• Synlab UK: Pan-European clinical laboratory services provider with extensive UK operations offering routine and specialized diagnostic testing. Comparable business model to Mayfair's general diagnostic testing across hematology, biochemistry, and specialized panels, with significantly larger geographic footprint.

Emerging players

• Thriva: UK digital health startup offering home blood testing kits with online results and health insights. Comparable to Mayfair's home sample collection channel and overlapping on hormone, cholesterol, and wellness panels, though Thriva is digital-first rather than lab-based.
• Forth: UK digital health platform offering home blood testing with personalized health insights and ongoing monitoring. Overlaps with Mayfair on hormone testing, women's health panels, and the digital/remote patient monitoring angle.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks7 records

Key highlights6 records

Customer concentration

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MAYFAIR LABORATORIES LIMITED